Coccidioidomycosis during pregnancy: a review and recommendations for management.

Abstract

Pregnancy is an established risk factor for the development of severe and disseminated coccidioidomycosis, particularly when infection is acquired during the later stages of gestation. Although recent studies suggest that the incidence of symptomatic coccidioidomycosis during pregnancy is decreasing and that outcome has improved, management is complicated by the observations that azole antifungal agents can be teratogenic when given to some women, particularly at high doses, early in pregnancy. This article summarizes the data on these issues and offers guidance on the management of coccidioidomycosis during pregnancy.

DOI: 10.1093/cid/cir410

2 Figures and Tables

0204060201220132014201520162017
Citations per Year

95 Citations

Semantic Scholar estimates that this publication has 95 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Bercovitch2011CoccidioidomycosisDP, title={Coccidioidomycosis during pregnancy: a review and recommendations for management.}, author={Robert S Bercovitch and Antonino Catanzaro and Brian S. Schwartz and Demosthenes Pappagianis and D. Heather Watts and Neil M Ampel}, journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America}, year={2011}, volume={53 4}, pages={363-8} }